Skip to content
10-Q

Quarterly Report

Ocular Therapeutix, Inc. OCUL

0001104659-25-105919

← back to feed
Filed
Nov 4, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 213.05M sh
Shares Diluted Q3 2025 · Sep 30, 2025 183.92M sh
Shares Diluted Q3 2025 · Sep 30, 2025 175.36M sh
Shares Diluted Q3 2025 · Sep 30, 2024 166.99M sh
Shares Diluted Q3 2025 · Sep 30, 2024 154.99M sh
Capex Q3 2025 · Sep 30, 2025 $9.17M
Capex Q3 2025 · Sep 30, 2024 $1.09M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$150.63M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$95.25M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $344.77M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $392.1M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $427.22M
Stockholders Equity Q3 2025 · Sep 30, 2025 $258.23M
Stockholders Equity Q3 2025 · Jun 30, 2025 $305.92M
Stockholders Equity Q3 2025 · Mar 31, 2025 $265.93M
Stockholders Equity Q3 2025 · Dec 31, 2024 $315.34M
Stockholders Equity Q3 2025 · Sep 30, 2024 $352.02M
Stockholders Equity Q3 2025 · Jun 30, 2024 $377.7M
Stockholders Equity Q3 2025 · Mar 31, 2024 $407.98M
Stockholders Equity Q3 2025 · Dec 31, 2023 $91.13M
Current Liabilities Q3 2025 · Sep 30, 2025 $49.29M
Current Liabilities Q3 2025 · Dec 31, 2024 $41.35M
Total Liabilities Q3 2025 · Sep 30, 2025 $152.65M
Total Liabilities Q3 2025 · Dec 31, 2024 $142.59M
Current Assets Q3 2025 · Sep 30, 2025 $386.98M
Current Assets Q3 2025 · Dec 31, 2024 $440.99M
Total Assets Q3 2025 · Sep 30, 2025 $410.88M
Total Assets Q3 2025 · Dec 31, 2024 $457.94M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.38
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.15
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.22
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.94
Eps Basic Q3 2025 · Sep 30, 2025 −$0.38
Eps Basic Q3 2025 · Sep 30, 2025 −$1.15
Eps Basic Q3 2025 · Sep 30, 2024 −$0.22
Eps Basic Q3 2025 · Sep 30, 2024 −$0.94
Sga Expense Q3 2025 · Sep 30, 2025 $16.02M
Sga Expense Q3 2025 · Sep 30, 2025 $46.72M
Sga Expense Q3 2025 · Sep 30, 2024 $12.24M
Sga Expense Q3 2025 · Sep 30, 2024 $46.05M
Rd Expense Q3 2025 · Sep 30, 2025 $52.36M
Rd Expense Q3 2025 · Sep 30, 2025 $146.3M
Rd Expense Q3 2025 · Sep 30, 2024 $37.05M
Rd Expense Q3 2025 · Sep 30, 2024 $86.65M
Net Income Q3 2025 · Sep 30, 2025 −$69.42M
Net Income Q3 2025 · Sep 30, 2025 −$201.29M
Net Income Q3 2025 · Jun 30, 2025 −$67.81M
Net Income Q3 2025 · Mar 31, 2025 −$64.05M
Net Income Q3 2025 · Sep 30, 2024 −$36.49M
Net Income Q3 2025 · Sep 30, 2024 −$145.12M
Net Income Q3 2025 · Jun 30, 2024 −$43.78M
Net Income Q3 2025 · Mar 31, 2024 −$64.85M
Operating Income Q3 2025 · Sep 30, 2025 −$68.7M
Operating Income Q3 2025 · Sep 30, 2025 −$200.26M
Operating Income Q3 2025 · Sep 30, 2024 −$46M
Operating Income Q3 2025 · Sep 30, 2024 −$121.21M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $1.77M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $4.98M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $1.56M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $4.4M
Revenue Q3 2025 · Sep 30, 2025 $14.54M
Revenue Q3 2025 · Sep 30, 2025 $38.7M
Revenue Q3 2025 · Sep 30, 2024 $15.43M
Revenue Q3 2025 · Sep 30, 2024 $46.64M